trending Market Intelligence /marketintelligence/en/news-insights/trending/x-7Xp_tMGBVnydmvHXyJRA2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Allergan completes $2.9B LifeCell acquisition


Climate Credit Analytics: Linking climate scenarios to financial impacts


Banking Essentials Newsletter: May Edition


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Allergan completes $2.9B LifeCell acquisition

Allergan PLC acquired LifeCell Corp. for approximately $2.9 billion in cash.

The acquisition adds LifeCell's portfolio of reconstruction and complex hernia surgery products to Allergan's existing portfolio of medical aesthetic products, breast implants and tissue expanders.

The merger will also give Allergan access to LifeCell's manufacturing and R&D operations in New Jersey.

Guggenheim Securities and Barclays served as financial advisors to Allergan, while Debevoise & Plimpton LLP were Allergan's lead legal counsel.